Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension
- 4 September 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 983, 176981
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertensionVascular Pharmacology, 2019
- Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertensionBiochemical Pharmacology, 2016
- Mechanisms of cytosolic targeting of matrix metalloproteinase‐2Journal of Cellular Physiology, 2011
- SERCA2a controls the mode of agonist-induced intracellular Ca2+ signal, transcription factor NFAT and proliferation in human vascular smooth muscle cellsJournal of Molecular and Cellular Cardiology, 2011
- Extracellular matrix alterations in hypertensive vascular remodelingJournal of Molecular and Cellular Cardiology, 2010
- Factors controlling the activity of the SERCA2a pump in the normal and failing heartBioFactors, 2009
- Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathioneBiochemical Pharmacology, 2009
- Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive ratsAtherosclerosis, 2008
- Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial windowCardiovascular Research, 2006
- Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilatorBiochemical Journal, 2004